These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Chronic obstructive pulmonary disease and the early stage of cor pulmonale: A perspective in treatment with pulmonary arterial hypertension-approved drugs. Sakao S Respir Investig; 2019 Jul; 57(4):325-329. PubMed ID: 31085118 [TBL] [Abstract][Full Text] [Related]
3. Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension. Goel K; Egersdorf N; Gill A; Cao D; Collum SD; Jyothula SS; Huang HJ; Sauler M; Lee PJ; Majka S; Karmouty-Quintana H; Petrache I Respir Res; 2022 Dec; 23(1):349. PubMed ID: 36522710 [TBL] [Abstract][Full Text] [Related]
4. Chronic Obstructive Pulmonary Disease and the Cardiovascular System: Vascular Repair and Regeneration as a Therapeutic Target. Karnati S; Seimetz M; Kleefeldt F; Sonawane A; Madhusudhan T; Bachhuka A; Kosanovic D; Weissmann N; Krüger K; Ergün S Front Cardiovasc Med; 2021; 8():649512. PubMed ID: 33912600 [TBL] [Abstract][Full Text] [Related]
5. Dysfunction of pulmonary vascular endothelium in chronic obstructive pulmonary disease: basic considerations for future drug development. Yang Q; Underwood MJ; Hsin MK; Liu XC; He GW Curr Drug Metab; 2008 Sep; 9(7):661-7. PubMed ID: 18781916 [TBL] [Abstract][Full Text] [Related]
6. [Sequels of lung diseases on cardiac function]. Rasche K; Orth M; Duchna HW Med Klin (Munich); 2006 Mar; 101 Suppl 1():44-6. PubMed ID: 16802518 [TBL] [Abstract][Full Text] [Related]
12. Cor pulmonale parvus in chronic obstructive pulmonary disease and emphysema: the MESA COPD study. Kawut SM; Poor HD; Parikh MA; Hueper K; Smith BM; Bluemke DA; Lima JA; Prince MR; Hoffman EA; Austin JH; Vogel-Claussen J; Barr RG J Am Coll Cardiol; 2014 Nov; 64(19):2000-9. PubMed ID: 25440095 [TBL] [Abstract][Full Text] [Related]
13. Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study. Miniati M; Monti S; Basta G; Cocci F; Fornai E; Bottai M Respir Res; 2011 Mar; 12(1):37. PubMed ID: 21450080 [TBL] [Abstract][Full Text] [Related]
14. Pulmonary hypertension and cor pulmonale in COPD. Lee-Chiong TL; Matthay RA Semin Respir Crit Care Med; 2003 Jun; 24(3):263-72. PubMed ID: 16088547 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary hypertension in chronic obstructive pulmonary disease and emphysema patients: prevalence, therapeutic options and pulmonary circulatory effects of lung volume reduction surgery. Opitz I; Ulrich S J Thorac Dis; 2018 Aug; 10(Suppl 23):S2763-S2774. PubMed ID: 30210830 [TBL] [Abstract][Full Text] [Related]
16. The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema. Barr RG Proc Am Thorac Soc; 2011 Nov; 8(6):522-7. PubMed ID: 22052931 [TBL] [Abstract][Full Text] [Related]
17. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil. Adnot S; Samoyeau R; Weitzenblum E Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542 [TBL] [Abstract][Full Text] [Related]
18. The vascular bed in COPD: pulmonary hypertension and pulmonary vascular alterations. Sakao S; Voelkel NF; Tatsumi K Eur Respir Rev; 2014 Sep; 23(133):350-5. PubMed ID: 25176971 [TBL] [Abstract][Full Text] [Related]